Radient Technologies Inc. (RDDTF)
OTCMKTS · Delayed Price · Currency is USD
0.0000
-0.0001 (-99.00%)
At close: Aug 15, 2025
Radient Technologies Market Cap
Radient Technologies has a market cap or net worth of $1.96 million as of August 22, 2025. Its market cap has decreased by -92.73% in one year.
Market Cap
1.96M
Enterprise Value
11.77M
Revenue
2.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since June 3, 2014, Radient Technologies's market cap has decreased from 25.11M to 1.96M, a decrease of -92.17%. That is a compound annual growth rate of -25.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 7, 2023 | 1.96M | -1.48% |
| Dec 30, 2022 | 1.99M | -86.17% |
| Dec 31, 2021 | 14.42M | -37.47% |
| Dec 31, 2020 | 23.06M | -74.31% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 610.45M |
| Glass House Brands | 554.44M |
| Nika Pharmaceuticals | 453.04M |
| American Oncology Network | 398.51M |
| CytoDyn | 365.94M |
| Northwest Biotherapeutics | 355.76M |